What is Alpha GPC used for?

Memory support; power output support; safety screen: low blood pressure; cholinergic sensitivity; anticholinergic medication conflicts.

Alpha GPC: Effects, Dose & Safety

At a glance

From this profile's structured data

Evidence: Grade D
Safety: Use caution with cholinergic drugs, low blood pressure, or sensitivity to headaches/nausea from choline donors.
Profile context: cholinergic system, neuronal membranes

Next stepsWhere to go next — guides & comparisons

If you want sharper focus → Focus guides
If you want to browse more compounds → All compounds

Quick stats

Evidence level: Preliminary evidence
Typical onset: Varies by prep
Safety rating: Use extra caution: Use caution
Best for: Cholinergic System, Neuronal Membranes
Avoid / review if: Known Hypersensitivity To Alpha GPC Or Its Excipients, Cardiovascular Conditions Or Autonomic Dysfunction Warrant Clinician Guidance Before Use, May Potentiate Cholinesterase Inhibitors Such As Donepezil Or Rivastigmine

Safety

Safety & Cautions

Use caution with cholinergic drugs, low blood pressure, or sensitivity to headaches/nausea from choline donors.

High caution

Caution level: High. Multiple caution categories apply, or the record uses avoid/contraindication language.

Interaction-AwareMedication or interaction context is explicitly noted.
Pregnancy/Breastfeeding CautionPregnancy or breastfeeding caution language is present.

Evidence Summary

Profile-wide ·D Preliminary

Evidence lens

Early signal that needs stronger human replication before practical claims.

PreliminaryPreliminary evidence

Human clinical evidence: Not the primary signal

Mechanistic / preclinical: Mechanism mapped — Metabolic Regulation · Neurotransmitter Modulation · Cellular Protection

Research maturity: Theoretical / mechanistic research — Mechanistic or unresolved evidence is kept separate from established human outcomes.

Safety boundary: Safety note available — Use caution with cholinergic drugs, low blood pressure, or sensitivity to headaches/nausea from choline donors.

This profile cites 1 human study.

Evidence Strength

Confidence estimate based on the design quality and consistency of published clinical trials.

Preliminary evidence

Alpha GPC has a preliminary evidence rating.

NootropicFocus

Citation density

0.5

Sources

Effects

Research recency

Mixed recency

Evidence Grade

Grade D: Preliminary / Theoretical Evidence

Evaluation of methodological rigor, population reach, and evidence alignment.

Design Match: Uncontrolled trial
Risk of Bias: Medium
Consistency: Not assessed

Strongest recorded design is a uncontrolled trial, drawn from 2 recorded studies, 2 in people.

How evidence grades work

Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.

Strong: Multiple RCTs, consistent direction, adequate effect size
Moderate: Some RCTs or consistent observational data in humans
Preliminary / Mixed: Animal or in-vitro only, or conflicting human data
Traditional / Theoretical: Traditional use only; no controlled human trials

Clinical Study Summaries (1)0 human evidence sources · 0 human trials · Participant totals not consistently reported · Consistency not yet classifiable

What the evidence actually shows

This table contains 1 structured source, including 0 human evidence sources; 0 are human trials.

Study	Design	N	Dose	Duration	Population	Outcome	Result & magnitude	Source
Disclosing new inhibitors by finding similarities in three-dimensional active-site architectures of polynuclear zinc phospholipases and aminopeptidases PubMed · Angew Chem Int Ed Engl · 2004 Background	Other / unclear The study design is not yet classified clearly enough to infer its place in the evidence hierarchy.	—	—	—	—	—	—	PubMed →

Study

Design

Dose

Duration

Population

Outcome

Result & magnitude

Source

Disclosing new inhibitors by finding similarities in three-dimensional active-site architectures of polynuclear zinc phospholipases and aminopeptidases

PubMed · Angew Chem Int Ed Engl · 2004

Background

Other / unclear

The study design is not yet classified clearly enough to infer its place in the evidence hierarchy.

—

PubMed →

How Alpha GPC Works

Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.

Mechanism Pathway — How Alpha GPC Works

CompoundTarget / ReceptorMechanismEffect / Outcome

Dosing

Common form: capsule or standardized extract
No standardized dose: Our source data records the usual product form for this ingredient but no studied dose. Preparations differ widely, so follow the standardization on the product you actually have and speak to a clinician before starting.

Mechanisms & biological pathways

Preclinical mechanism details from scientific profiles; these represent plausible pathways but do not guarantee clinical efficacy in humans.

Metabolic Regulation
Neurotransmitter Modulation
Cellular Protection
Vascular Function Support
Neuroprotective Activity
Lipid Metabolism Support

Guides that use Alpha GPC

Goal guides

cognition

Condition guides

Also in this cluster

ADHD & Focus Support guide →

Continue exploring

Related research paths

Related Compounds

Compounds connected by the same goals, effects, or research topics.

Related Herbs

Botanicals connected by the same goals, effects, or research topics.

Related Guides

Deeper context, comparisons, and practical research paths.

Related Safety Pages

Safety checks and cautions relevant to this decision.

Deeper context, comparisons, and practical research paths.

Best Supplements For Sleep

Compare & Sourcing

Compare side-by-side tradeoffs or verify active marker guidelines.

Related alternatives

Black Tea Garlic (Allium Sativum)Arjuna Blueberry

Herbs for similar conditions

Garlic Allium sativum Ginkgo Garlic Hibiscus

Tradeoffs

Free safety checklist

Get the Alpha GPC evidence notes

Occasional research updates, safety context, and product-quality checks for supplement decisions.

We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.

Safety first · Harm reduction

This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.

Learn how we evaluate confidence, safety, and intensity on the methodology page.

Editorial Review

Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.

Editorial Standards →

Help improve this profile

Was this useful for your research?

These controls record only the page and the structured choice you make when analytics consent is enabled. Please don’t include personal medical information in research requests.

Was this evidence summary clear?

Did you find what you were researching?

Suggest an ingredient, comparison, or study →

← Back to compounds library Safety checker →